Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

VIR - Vir Biotechnology, Inc. Financial... | Finranks

Home

/

VIR

V

Vir Biotechnology, Inc. (VIR)

NMS – Real Time Price. Currency in USD

8.92

-0.01 (-0.11%)

Market open: Aug 12, 2026, 10:11 AM EDT

8.93

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

69M

74M

86M

1.62B

Cost of goods sold

-12M

-15M

-22M

-162M

Gross Profit

57M

59M

64M

1.45B

Operating expenses (excl. COGS)

-525M

-582M

-725M

-621M

Operating Income

-468M

-523M

-661M

833M

Non-operating income, total

30M

316K

33M

-79M

Pretax income

-438M

-523M

-628M

754M

Equity in earnings

0

0

0

0

Taxes

-217K

1M

13M

-238M

Non-controlling/minority interest

0

0

56K

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-438M

-522M

-615M

516M

Discontinued operations

0

0

0

0

Net income

-438M

-522M

-615M

516M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

1.02B-28.0%

1.42B-27.4%

1.96B-35.8%

3.05B

Total current assets

514M

1.04B

1.59B

2.52B

Total non-current assets

511M

381M

372M

533M

Total liabilities

260M-5.0%

273M-26.1%

370M-62.0%

974M

Total current liabilities

93M

120M

175M

511M

Total non-current liabilities

167M

154M

194M

463M

Total equity

765M

1.15B

1.59B

2.08B

Total liabilities & shareholders' equities

1.02B

1.42B

1.96B

3.05B

Total debt

98M-0.0%

98M-21.4%

125M-2.7%

128M

Name

2025

2024

2023

2022

Cash from operating activities

-392M

-446M

-779M

1.66B

Cash from investing activities

310M

499M

165M

-1.19B

Cash from financing activities

4M

4M

7M

35M

Free cash flow

-397M+12.6%

-454M+43.3%

-800M-150.2%

1.60B